GlassScriptPhysician profile
Tabish Aijaz
NPI 1417319732
$2,057.23
in general payments reported to CMS, 2019-2025
12 companies · $1,749 in 2025
The $1,749 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $273 · 2023: $35.59 · 2025: $1,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585 · Travel and Lodging: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.54 |
| Travel and Lodging | $199.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $769.15 | 2025 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $439.83 | 2025 | Prospera |
| Globus Medical, INC. | $232.33 | 2025 | Senza |
| Boston Scientific Corporation | $181.65 | 2021-2025 | Intracept |
| Abbott Laboratories | $137.30 | 2021 | |
| Medtronic, INC. | $108.71 | 2025 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $52.95 | 2021 | |
| Octapharma USA, INC. | $35.59 | 2023 | Balfaxar, Fibryga, Octaplas |
| Gilead Sciences, INC. | $34.36 | 2025 | |
| Exact Sciences Corporation | $27.79 | 2025 | Cologuard Collection Kit |
| Si-Bone, INC. | $24.15 | 2025 | |
| Mml US, INC. | $13.42 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabish Aijaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.